Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 5 46-5, 1999, Pages

  Sobey, Christopher G ^a   Quan, Lilly ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

1H 1,2,4 oxadiazolo 4,3, a quinoxalin 1 one; Adenosine; Basilar artery; Guanosine 3',5' cyclic monophosphate; Nitric oxide; Soluble guanylate cyclase; Zaprinast

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; ACETYLCHOLINE; ADENOSINE; CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; ISOBUTYLMETHYLXANTHINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; ZAPRINAST;

ANIMAL MODEL; ARTICLE; BASILAR ARTERY; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; EXPERIMENTAL MODEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; TOPICAL DRUG ADMINISTRATION; VASODILATATION;

EID: 0032714639     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.5.h1718     Document Type: Article

References (45)

1. Beavo, J. A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75: 725-748, 1995.
2. Clower, B. R., Y. Yamamoto, L. Cain, D. E. Haines, and R. R. Smith. Endothelial injury following experimental subarachnoid hemorrhage in rats: effects on brain blood flow. Anat. Rec. 240: 104-114, 1994.
3. Cook, D. A. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol. Ther. 66: 259-284, 1995.
4. Delgado, T. J., J. Brismar, and N. A. Svendgaard. Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16: 595-602, 1985.
5. Edwards, D. H., J. V. Byrne, and T. M. Griffith. The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J. Neurosurg. 76: 830-837, 1992.
6. Faraci, F. M., and D. D. Heistad. Role of ATP-sensitive potassium channels in the basilar artery. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H8-H13, 1993.
7. Faraci, F. M., D. D. Heistad, and W. G. Mayhan. Role of large arteries in regulation of blood flow to brain stem in cats. J. Physiol. (Lond.) 387: 115-123, 1987.
8. Garthwaite, J., E. Southam, C. L. Boulton, E. B. Nielsen, K. Schmidt, and B. Mayer. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48: 184-188, 1995.
9. Hatake, K., I. Wakabayashi, E. Kakishita, and S. Hishida. Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage. Stroke 23: 1111-1117, 1992.
10. Kanamaru, K., B. K. A. Weir, J. M. Findlay, C. A. Krueger, and D. A. Cook. Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage. J. Neurosurg. 71: 909-915, 1989.
11. Kassell, N. F., T. Sasaki, A. R. T. Colohan, and G. Nazar. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16: 562-572, 1985.
12. Kasuya, H., B. K. A. Weir, M. Nakane, J. S. Pollock, L. Johns, L. S. Marton, and K. Stefansson. Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J. Neurosurg. 82: 250-255, 1995.
13. G-monomethyl-L-arginine in canine basilar artery. Stroke 22: 1399-1404, 1991.
14. Kim, P., R. R. Lorenz, T. M. J. Sundt, and P. M. Vanhoutte. Release of endothelium-derived relaxing factor after subarachnoid hemorrhage. J. Neurosurg. 70: 108-114, 1989.
15. Kim, P., V. B. Schini, T. M. Sundt, and P. M. Vanhoutte. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ. Res. 70: 248-256, 1992.
16. Kim, P., T. M. Sundt, and P. M. Vanhoutte. Alterations in endothelium-dependent responsiveness of the canine basilar artery after subarachnoid hemorrhage. J. Neurosurg. 69: 239-246, 1988.
17. Lai, F. M., A. Cobuzzi, C. Shepherd, T. Tanikella, A. Hoffman, and P. Cervoni. Endothelium-dependent basilar and aortic vascular responses in normotensive and coarctation hypertensive rats. Life Sci. 45: 607-614, 1989.
18. Macdonald, R. L., and B. K. A. Weir. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22: 971-982, 1991.
19. Mackert, J. L., A. A. Parsons, M. Wahl, and L. Schilling. Mediation of endothelium-dependent relaxation: different response patterns in rat and rabbit basilar artery. Neurol. Res. 19: 521-526, 1997.
20. Meyer, R. B., and J. P. Miller. Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzyme activity. Life Sci. 14: 1019-1040, 1974.
21. 2+ channel antagonist, AJ-3941, of loss of endothelium-dependent relaxation after subarachnoid hemorrhage in rats. Eur. J. Pharmacol. 315: 297-303, 1996.
22. Nakao, K., H. Murata, K. Kanamaru, and S. Waga. Effects of nitroglycerin on vasospasm and cyclic nucleotides in a primate model of subarachnoid hemorrhage. Stroke 27: 1882-1888, 1996.
23. Nicholson, C. D., R. A. J. Challiss, and M. Shahid. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. Sci. 12: 19-27, 1991.
24. Nishimura, Y., H. Usui, A. Suzuki, N. Kajimoto, and Y. Yamanishi. Relaxant response of isolated basilar arteries to calcitonin gene-related peptide in stroke-prone spontaneously hypertensive rats. Jpn. J. Pharmacol. 59: 333-338, 1992.
25. Nishizawa, S., S. Yamamoto, and K. Uemura. Interrelation between protein kinase C and nitric oxide in the development of vasospasm after subarachnoid hemorrhage. Neurol. Res. 18: 89-95, 1996.
26. Nishizawa, S., S. Yamamoto, T. Yokoyama, H. Ryu, and K. Uemura. Chronological changes of arterial diameter, cGMP, and protein kinase C in the development of vasospasm. Stroke 26: 1916-1921, 1995.
27. Onoue, H., N. Kaito, M. Akiyama, M. Tomii, S. Tokudome, and T. Abe. Altered reactivity of human cerebral arteries after subarachnoid hemorrhage. J. Neurosurg. 83: 510-515, 1995.
28. Onoue, H., and Z. S. Katusic. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide. Brain Res. 785: 107-113, 1998.
29. Onoue, H., and Z. S. Katusic. The effect of subarachnoid hemorrhage on mechanisms of vasodilation mediated by cyclic adenosine monophosphate. J. Neurosurg. 89: 111-117, 1998.
30. Onoue, H., and Z. S. Katusic. Role of potassium channels in relaxations of canine middle cerebral arteries induced by nitric oxide donors. Stroke 28: 1264-1271, 1997.
31. Onoue, H., and Z. S. Katusic. Subarachnoid hemorrhage and the role of potassium channels in relaxations of canine basilar artery to nitrovasodilators. J. Cereb. Blood Flow Metab. 18: 186-195, 1998.
32. Parfenova, H., M. Shibata, S. Zuckerman, R. Mirro, and C. W. Leffler. Cyclic nucleotides and cerebrovascular tone in newborn pigs. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1972-H1982, 1993.
33. Smith, R. R., G. M. Clower, N. Grotendorst, N. Yabuno, and J. M. Cruse. Arterial wall changes in early human vasospasm. Neurosurgery 16: 171-176, 1985.
34. Sobey, C. G., and T. M. Cocks. Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. Stroke 29: 1439-1444, 1998.
35. Sobey, C. G., and F. M. Faraci. Effect of nitric oxide and potassium channel agonists and inhibitors on basilar artery diameter. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H256-H262, 1997.
36. Sobey, C. G., and F. M. Faraci. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Stroke 28: 837-843, 1997.
37. Sobey, C. G., and F. M. Faraci. Inhibitory effect of 4-aminopyridine on responses of the basilar artery to nitric oxide. Br. J. Pharmacol. 126: 1437-1443, 1999.
38. Sobey, C. G., and F. M. Faraci. Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin. Exp. Pharmacol. Physiol. 25: 867-876, 1998.
39. Sobey, C. G., D. D. Heistad, and F. M. Faraci. Effect of subarachnoid hemorrhage on dilatation of basilar artery in vivo. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H126-H132, 1996.
40. Sutter, B., S. Suzuki, A. S. Arthur, N. F. Kassell, and K. S. Lee. Effects of subarachnoid hemorrhage on vascular responses to calcitonin gene-related peptide and its related second messengers. J. Neurosurg. 83: 516-521, 1995.
41. Weir, B. The pathophysiology of cerebral vasospasm. Br. J. Neurosurg. 9: 375-390, 1995.
42. Willette, R. N., A. O. Shiloh, C. F. Sauermelch, A. Sulpizio, M. P. Michell, L. B. Cieslinski, T. J. Torphy, and E. H. Ohlstein. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors. J. Cereb. Blood Flow Metab. 17: 210-219, 1997.
43. Yakubu, M. A., M. Shibata, and C. W. Leffler. Subarachnoid hematoma attenuates vasodilation and potentiates vasoconstriction induced by vasoactive agents in newborn pigs. Pediatr. Res. 36: 589-594, 1994.
44. Yamamoto, S., S. Nishizawa, T. Yokoyama, H. Ryu, and K. Uemura. Subarachnoid hemorrhage impairs cerebral blood flow response to nitric oxide but not to cyclic GMP in large cerebral arteries. Brain Res. 757: 1-9, 1997.
45. Zuccarello, M., C. L. Bonasso, A. I. Lewis, N. Sperelakis, and R. M. Rapoport. Relaxation of subarachnoid hemorrhage-induced spasm of rabbit basilar artery by the K+ channel activator cromakalim. Stroke 27: 311-316, 1996.